Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1999
06/10/1999WO1999008684A3 Solutions containing azasteroids
06/10/1999WO1999007737A3 Lsr receptor, cloning and uses
06/10/1999WO1999004765A3 Pharmaceutical compositions containing an effervescent acid-base couple
06/10/1999WO1998040080A9 Oxyalkylene phosphate compounds and uses thereof
06/10/1999DE19812413C1 Transdermal therapeutic system for administration of oxybutynin
06/10/1999DE19754573A1 Pharmazeutische Zusammensetzung zur Behandlung von Schlaganfall und Schädel-Hirn-Trauma A pharmaceutical composition for the treatment of stroke and traumatic brain injury
06/10/1999DE19754324A1 Easily prepared oral dosage forms for acid-labile drugs, especially proton pump inhibitors
06/10/1999DE19754082A1 Methode zur Bekämpfung der Fettleibigkeit Method to combat obesity
06/10/1999DE19754054A1 Use of di:carboxylic acid and oil or wax
06/10/1999DE19753504A1 Mittel zur Bekämpfung von Neospora spec Means of combating Neospora spec
06/10/1999DE19753383A1 Verwendung von Abciximab zur Behandlung von Mikrozirkulationsstörungen Use of abciximab for treatment of microcirculatory disorders
06/10/1999DE19753363A1 15-Methyl-cyclopropanosteroide und Verfahren zu ihrer Herstellung 15-methyl-cyclopropanosteroide and processes for their preparation
06/10/1999DE19753321A1 Verfahren zur Herstellung und Verwendung von Lysinformiat A process for the preparation and use of Lysinformiat
06/10/1999CA2313243A1 Nucleic acid encoding mammalian ubr1
06/10/1999CA2313050A1 Amino-benzothiazole derivatives
06/10/1999CA2313029A1 Improved method for avoiding the degradation of an active principle
06/10/1999CA2312851A1 Therapeutic and diagnostic methods dependent on cyp2a enzymes
06/10/1999CA2312824A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
06/10/1999CA2312811A1 Synergistic antimicrobial compositions
06/10/1999CA2312778A1 Combined chemo-immunotherapy with liposomal drugs and cytokines
06/10/1999CA2312749A1 Pdgf receptor kinase inhibitory compounds and compositions, method for synthesis of same and use of same for treatment of proliferate disorders
06/10/1999CA2312699A1 Pharmaceutical use of cromoglycic acid compound
06/10/1999CA2312464A1 Oral antioxidant preparation comprising selenium and reduced glutathione
06/10/1999CA2312396A1 Agents for combating neospora spec
06/10/1999CA2312366A1 Inhibitors of farnesyl-protein transferase
06/10/1999CA2312334A1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors
06/10/1999CA2312023A1 Method for inhibiting cytokine production by cells
06/10/1999CA2312002A1 Human rnase h and compositions and uses thereof
06/10/1999CA2311930A1 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
06/10/1999CA2311929A1 A process for the reduction of oxiranyl epothilones to olefinic epothilones
06/10/1999CA2311798A1 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
06/10/1999CA2311796A1 Zwitterionic fatty acid compounds for anti-inflammation
06/10/1999CA2311780A1 Porous hydroxyapatite particles as carriers for drug substances
06/10/1999CA2311731A1 Minoxidil-containing liquid preparation composition
06/10/1999CA2310826A1 Soft-pellet drug and process for the preparation thereof
06/10/1999CA2310629A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
06/10/1999CA2310541A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening
06/10/1999CA2310054A1 Thiophene-sulfonamide compounds
06/10/1999CA2310008A1 1,3,4-thiadiazoles derivatives as kyn-oh inhibitors
06/10/1999CA2310003A1 Chemical synthesis of 6-o-alkyl erythromycin c
06/10/1999CA2309977A1 6-o-alkyl derivatives of erythronolide b
06/10/1999CA2309969A1 Benzenesulfonamide compounds
06/10/1999CA2309347A1 Thrombin inhibitors
06/10/1999CA2309228A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/09/1999EP0921197A2 Human disintegrin metalloprotease related to drosophila kuz gene
06/09/1999EP0921193A1 Carrier: DNA complexes containing DNA encoding anti-angiogenic peptides and their use in gene therapy
06/09/1999EP0921130A2 Steroid sulphatase inhibitors
06/09/1999EP0921125A1 1,3,8-Triaza-spiro 4,5 decan-4-on derivatives
06/09/1999EP0921124A1 Benzothiophene derivatives useful in therapy
06/09/1999EP0921123A1 Novel thiophene derivatives and drug compositions containing the same
06/09/1999EP0921121A1 Intermediates to therapeutic nucleosides
06/09/1999EP0921120A1 Selective beta 3 adrenergic agonists
06/09/1999EP0921119A1 Pyrrole derivatives, process for their preparation and pharmaceutical compositions containing them
06/09/1999EP0921117A2 Acylguanidines
06/09/1999EP0921116A1 N-(4-carbamimido-phenyl)-glycine amide derivatives
06/09/1999EP0921114A1 Intermediates to therapeutic nucleosides
06/09/1999EP0920870A1 Flavanone-containing composition
06/09/1999EP0920869A1 Stable aspirin-containing preparations for external use
06/09/1999EP0920867A1 Pyrido[2,3-a]pyrazine derivatives as PDE-IV and TNF inhibitors
06/09/1999EP0920866A1 Preventives/remedies for muscle tissue degenerations
06/09/1999EP0920865A1 Pharmaceutical compositions containing Norastemizole
06/09/1999EP0920864A1 Combination therapy including a specific beta-3 agonist and an anorectic agent
06/09/1999EP0920863A1 2-Aryl-3-aroylbenzo(b)thiophenes useful for the treatment of estrogen deprivation syndrome
06/09/1999EP0920862A1 2-Arylbenzo b thiophenes useful for the treatment of estrogen deprivation syndrome
06/09/1999EP0920857A2 Oral composition for the treatment of halitosis
06/09/1999EP0920632A1 Materials and methods for detection and treatment of immune system dysfunctions
06/09/1999EP0920630A2 Prion protein binding proteins and uses thereof
06/09/1999EP0920534A1 MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA ($g(a)), HNF-1$g(b) AND HNF-4$g(a)
06/09/1999EP0920528A1 Synthetic protein folding catalysis
06/09/1999EP0920527A1 SYNTHESIS OF beta-LACTAM ANTIBACTERIALS USING SOLUBLE SIDE CHAIN ESTERS AND ENZYME ACYLASE
06/09/1999EP0920515A1 A NOVEL HUMAN mRNA EDITING ENZYME
06/09/1999EP0920512A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
06/09/1999EP0920506A1 Human dbi/acbp-like protein
06/09/1999EP0920505A1 Mammalian cell surface antigens; related reagents
06/09/1999EP0920500A1 Human proteolipid
06/09/1999EP0920499A2 Polynucleotides encoding secreted proteins
06/09/1999EP0920494A2 Pro-protein converting enzyme
06/09/1999EP0920451A1 Novel peptides suitable for use in antigen specific immunosuppressive therapy
06/09/1999EP0920448A1 Truncated glial cell line-derived neurotrophic factor
06/09/1999EP0920447A1 Process of purification of cyclosporin
06/09/1999EP0920441A1 7alpha-(epsilon-aminoalkyl)-estratrienes, process for preparing the same, pharmaceutical preparations containing said 7alpha-(epsilon-aminoalkyl)-estratrienes and their use for preparing medicament
06/09/1999EP0920438A2 N6 heterocyclic substituted adenosine derivatives
06/09/1999EP0920437A1 Modified oligosaccharides
06/09/1999EP0920434A2 Bis-platinum complexes with polymethylene derivatives as ligands having antitumor activity
06/09/1999EP0920431A1 Thienopyrimidines
06/09/1999EP0920430A1 Purine derivatives and their use as anti-coagulants
06/09/1999EP0920429A1 Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
06/09/1999EP0920428A1 Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
06/09/1999EP0920426A1 New thiazole derivatives with phosphodiesterase-inhibiting effect
06/09/1999EP0920425A1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
06/09/1999EP0920424A1 Non-peptide bombesin receptor antagonists
06/09/1999EP0920422A1 Crytalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide
06/09/1999EP0920421A1 Isoxazoline derivatives useful as antimicrobials
06/09/1999EP0920419A1 Compounds, compositions and methods for treating influenza
06/09/1999EP0920418A1 Substituted imidazolium salts and their use for the inhibition of protein ageing
06/09/1999EP0920417A1 Il-8 receptor antagonists
06/09/1999EP0920416A1 Naphtholactams and lactones as bone morphogenetic protein active agents
06/09/1999EP0920414A1 Matrix metalloproteinase inhibitors
06/09/1999EP0920345A1 Iontophoretic delivery of cell adhesion inhibitors
06/09/1999EP0920326A1 Antithrombotic materials and methods
1 ... 6489 6490 6491 6492 6493 6494 6495 6496 6497 6498 6499 6500 6501 6502 6503 6504 6505 6506 6507 6508 6509 ... 7860